News Briefs

EDIT CONNECT

THIS ISSUE:

Global News

Tools & Technology

Diagnostics

Omics & Systems Biology

Research & Development

Contract Research Services

Products & Services

DAILY NEWS:

News Briefs

Bench Press

Top Story

CONFERENCES AND EXHIBITIONS:

LabAutomation Product Showcase

AACR Product Showcase

SBS Product Showcase

ASMS Product Showcase

DDT Product Showcase

SPECIAL REPORTS:

ddn MARKET RESEARCH:

INDUSTRY CALENDAR:

June 6-7, 2013

European Lab Automation - Hamburg, Germany

June 12-15, 2013

ISSCR 11th Annual Meeting - Boston, Ma

More Events

E-NEWSLETTER SUBSCRIPTION:

News Briefs

05-16-2013

Roche, QB3 unite for startups

Code: E05161301

05-15-2013

AbbVie, Alvine Pharmaceuticals to collaborate on potential celiac disease treatment

Code: E05151301

05-14-2013

Astellas to close down OSI Pharmaceuticals, Perseid Therapeutics

Code: E05141301

05-13-2013

Theravance and Elan enter into a billion-dollar royalty participation deal

Code: E05131301

05-09-2013

Merck, GSK make commitments to GAVI Alliance to provide discounted HPV vaccines

Code: E05091301

05-08-2013

Takeda acquires Inviragen for $35 million up front

Code: E05081300

05-07-2013

Concert in tune with Celgene for $300 million deal

Code: E05081301

05-07-2013

$112 million ADC collaboration marks third Bristol-Myers Squibb/Ambrx deal in two years

Code: E05081302

05-07-2013

Astellas, Drais to form virtual company

Code: E05071301

05-06-2013

Prostate cancer survey indicates strong uptake with regard to new hormone-based agents

Code: E05061301

05-06-2013

Regeneron expands ophthalmology portfolio by acquiring rights to Sanofi development programs

Code: E05031301

05-02-2013

Foundation Medicine, Memorial Sloan-Kettering partner on hematologic cancer test

Code: E05021301

05-01-2013

QIAGEN bolsters its database offerings with Ingenuity acquisition

Code: E04301301

05-01-2013

Real Time Genomics, J. Craig Venter Institute announce collaborations

Code: E05011301

04-29-2013

FORMA Therapeutics forges $200 million deal with Celgene

Code: E04291301

04-29-2013

Theravance to split in two

Code: E04261301

04-25-2013

OPKO, PROLOR sign definitive merger agreement

Code: E04241301

04-25-2013

Research institutions, hospitals announce London Lung Cancer Initiative

Code: E04251301

04-23-2013

Refining the aim in the hunt for tumor cells

Code: E04241301

04-23-2013

OHSU teams with Intel to decode root causes of cancer and other complex diseases

Code: E04241302

04-23-2013

GSK, Avalon Ventures announce $495 million startup deal

Code: E04231301

04-22-2013

A rallying point for cancer research

Code: E04221302

04-22-2013

Merck and Bristol-Myers Squibb to jointly study potential hepatitis C therapy

Code: E04221301

04-21-2013

Cerecor gains rights to potential depression treatment from Merck

Code: E04191301

04-18-2013

Lilly acquires PET tracers for Alzheimer's imaging

Code: E04171301

04-18-2013

Myriad announces commercial agreement with RainDance Technologies

Code: E04181301

04-16-2013

Bristol-Myers Squibb teams up with Santaris Pharma

Code: E04161301

04-15-2013

Thermo Fisher Scientific to acquire Life Technologies for more than $13 billion

Code: E04151301

04-12-2013

Mobidiag, Genewave and Amplidiag merge to become leading innovator in molecular diagnostics

Code: 04121301

04-11-2013

Quest Diagnostics, Matrix-Bio announce licensing agreement

Code: E04111301

04-10-2013

NCI, CvergenX to partner on radiosensitivity assay

Code: E04101301

04-09-2013

Roche and Isis Pharmaceuticals form $392 million alliance against Huntington's disease

Code: E04101301

04-09-2013

Stopping RA before it starts

Code: E04101302

04-09-2013

Anacor inks agreement with Gates Foundation

Code: E04091301

04-08-2013

Resverlogix Corp. to spin out RVX Therapeutics Inc.

Code: E04051301

04-08-2013

Astellas and Ambrx sign $300 million ADC oncology deal

Code: E04051301

04-04-2013

CollabRx teams up with OncoDNA

Code: E04041301

04-03-2013

BIND Therapeutics, Pfizer announce global collaboration

Code: E04031301

04-02-2013

Merz Pharma announces $383.5 million proposal for Obagi

Code: E04021301

04-01-2013

ArQule regains rights to AKT compounds from Daiichi Sankyo

Code: E04011301

03-31-2013

Quartette approval represents next generation in women's contraceptives, says Teva

Code: E03291301

03-28-2013

Lundbeck to collaborate with Otsuka Pharmaceutical for Alzheimer's drug candidate

Code: E03271301

03-28-2013

Edison, DSP announce R&D agreement

Code: E03281301

03-26-2013

Shire sees value in SARcode

Code: E03271301

03-26-2013

National Brain Tumor Society announces launch of the Defeat GBM Research Collaborative

Code: E03271302

03-26-2013

Third Rock Ventures stocks up with $516 million new fund

Code: E03271303

03-24-2013

Xceleron and JCL Bioassay announce partnership in early clinical investigations

Code: E03221301

03-22-2013

BGI, H3 initiate cancer data partnership

Code: E03211301

03-20-2013

Valeant acquires Obagi Medical Products

Code: E03201301

03-19-2013

Wellcome Trust Sanger, Mass. General, Blueprint to collaborate on cancer targets

Code: E03191301

03-18-2013

ChromoTek licenses Chromobody technology for high-content drug profiling to Bayer

Code: E03181301

03-17-2013

Novartis lung cancer drug earns breakthrough therapy designation from FDA

Code: E03151301

03-15-2013

Receptos links up with AbbVie to develop potential orphan disease drug

Code: E03141301

03-14-2013

Merck, Luminex to develop AD companion diagnostic device

Code: E03131300

03-13-2013

Shire enters neonatology field with Premacure acquisition

Code: E03121301

03-12-2013

EU launches $12 million project to scour the deep seas for bioactive compounds

Code: E03131301

03-12-2013

Ajinomoto agrees to acquire Althea Technologies for about $175 million

Code: E03131302

03-11-2013

Cubist obtains remaining rights for ceftolozane from Astellas

Code: E03011301

03-11-2013

Biovest seeks bankruptcy protection for restructuring

Code: E03081301

03-07-2013

MRC Technology, MS Society call for MS targets

Code: E03061301

03-07-2013

Agilent joins Applied Proteomics in mass spec deal

Code: E03071301

03-06-2013

Life Technologies links up with Harvard in stem cell deal

Code: E03051301

03-05-2013

Elan introduces new cash dividend policy for shareholders

Code: E03041301

03-03-2013

Capsugel acquires Encap Drug Delivery

Code: E03011301

02-28-2013

Jazz, Concert Pharmaceuticals make music with license agreement

Code: E02271300

02-28-2013

Mylan to acquire Agila Specialties

Code: E02281301

02-26-2013

Elan Corp. to buy back $1 billion of stock after Tysabri sale

Code: E02271301

02-26-2013

LEO Pharma and 4SC Discovery form pact worth as much as $125 million

Code: E02271302

02-26-2013

Royalty Pharma proposes to acquire Elan, gets cold shoulder instead

Code: E02261301

02-25-2013

FDA grants fast-track designation for MediciNova's compound to treat meth dependence

Code: E02251301

02-21-2013

Abbott, Janssen, Pharmacyclics to collaborate on leukemia CDx

Code: E02211301

02-20-2013

Cepheid, Knight Cancer Institute embark on collaboration

Code: E02201301

02-19-2013

QIAGEN joins WaferGen in co-marketing agreement

Code: E02191301

02-18-2013

Optibrium and Lhasa seek to bring better toxicity prediction to chemists’ desktops

Code: E02151301

02-14-2013

Pantarhei Bioscience sells estrogen therapy to Uteron Pharma

Code: E02131300

02-14-2013

QIAGEN, Lilly to develop companion diagnostics

Code: E02141301

02-13-2013

Novozymes, EpiVax join forces

Code: E02121301

02-12-2013

Improving aim against tumors with Accurins

Code: E02131301

02-12-2013

FDA approves Celgene's multiple myeloma drug

Code: E02131302

02-11-2013

Perrigo acquires Rosemont Pharmaceuticals for $283 million

Code: 02111301

02-11-2013

Taro and Sun terminate merger plans

Code: E02081301

02-07-2013

European drug discovery initiative launched among academia, industry

Code: E02071301

02-06-2013

Biogen Idec purchases TYSABRI interest from Elan

Code: E02061301

02-05-2013

Merck Serono, Opexa Therapeutics team up for MS therapy

Code: E02051301

02-04-2013

The Medicines Company and Alnylam form strategic alliance

Code: E02041301

01-31-2013

Weill Cornell, NewYork-Presbyterian establish the Institute for Precision Medicine

Code: E01311301

01-30-2013

Life Technologies spearheads influenza initiative

Code: E01291301

01-30-2013

BioClinica, CoreLab Partners to be acquired, merged

Code: E01301301

01-28-2013

Novartis quells speculation about selling Roche share; AstraZeneca picks up where J&J left off

Code: E01251301

01-24-2013

Allergan to acquire MAP Pharmaceuticals for $958 million

Code: E01231301

01-24-2013

Baxter acquires hemophilia A assets from Inspiration, Ipsen

Code: E01241301

01-22-2013

Life Technologies might be on the market

Code: E01231301

01-22-2013

A ‘crucial' partnership

Code: E01231202

01-22-2013

SV Bio, Mayo Clinic join forces

Code: E01221300

01-21-2013

Botox receives yet another indication, this time for overactive bladder

Code: E01211301

01-17-2013

PsiOxus Therapeutics lands $3.3 million DTRA contract

Code: E01161301

01-17-2013

CNGB-Shenzhen, NMNH announce biorepository agreement

Code: E01171301

01-15-2013

Vanderbilt, AstraZeneca partner on neurological candidates

Code: E01151301

01-14-2013

Second tranche for Aileron brings total round to $42 million

Code: E01141301

01-14-2013

MIND Institute researchers receive grants from Autism Speaks

Code: E01111301

01-10-2013

Shire expands orphan disease repertoire with Lotus acquisition

Code: E01091301

01-09-2013

Sherley v. Sebelius put to bed

Code: E01081301

01-08-2013

A new connection with Genection

Code: 01091301

01-08-2013

Amgen and BIND enter into roughly $180 million nanomedicine deal

Code: 01091302

01-07-2013

Illumina agrees to acquire Verinata Health

Code: E01071301

01-07-2013

Cellular Dynamics stikes agreement with AstraZeneca to use iPSC-derived human cells in drug discovery research

Code: E01041301

01-03-2013

Squaring off against SMA

Code: E01031301

01-02-2013

AbbVie born from Abbott's separated pharmaceuticals business

Code: E01021301

12-28-2012

Perrigo acquires remaining stake in Cobrek Pharmaceuticals for approximately $45 million

Code: E12281201

12-28-2012

Takeda and Amylin terminate $1 billion anti-obesity pact

Code: E12271201

12-21-2012

Reckitt Benckiser completes tender offer for Schiff Nutrition

Code: E12201201

12-19-2012

OpGen partners with UC Davis in 100K Genome Project

Code: E12191201

12-18-2012

GE Healthcare Life Sciences, CDI announce license agreement

Code: E12181201

12-17-2012

Vivalis to acquire and merge with Intercell for $174 million

Code: E12171202

12-17-2012

Titan Pharmaceuticals and Braeburn Pharmaceuticals sign license agreement worth up to $305 million

Code: E12171201

12-13-2012

Gilead nabs YM BioSciences for $510 million

Code: E12121200

12-13-2012

Registries for All Diseases named Sanofi US' Collaborate Activate Innovation Challenge winner

Code: E12131201

12-12-2012

ADA kicks off multiyear diabetes initiative

Code: E12111201

12-11-2012

Biogen Idec and Isis Pharmaceuticals enter drug development pact worth as much as $630 million

Code: E12121201

12-10-2012

Amgen to acquire deCODE genetics for $415 million

Code: E12101201

12-10-2012

GSK and MD Anderson enter into cancer immune therapy deal potentially worth more than $335 million

Code: E12071201

12-07-2012

Academia, industry join in massive iPS partnership

Code: E12061201

12-05-2012

DELSIA, Seaside Therapeutics announce biomarker partnership

Code: E12041201

12-05-2012

Baxter to acquire Gambro AB

Code: E12051201

12-03-2012

Optimer Pharmaceuticals and AstraZeneca strike $23 million deal for C. difficile drug

Code: E12031201

12-03-2012

BioCryst and Presidio call off planned merger

Code: E11301201

11-29-2012

Selecta signs with Sanofi

Code: E11281200

11-29-2012

Smith & Nephew to acquire Healthpoint Biotherapeutics

Code: E11291201

11-27-2012

Big investment in developing markets, a new joint venture and a business on the block

Code: E11281201

11-27-2012

BASF makes roughly $850 million takeover bid for Pronova BioPharma

Code: E11281202

11-27-2012

Complete Genomics continues to spurn Illumina offer

Code: E11271201

11-21-2012

Pfizer, CFFT expand cystic fibrosis collaboration

Code: E11201201

11-19-2012

Illumina admits it’s the mystery company that made unsolicited bid for Complete Genomics

Code: E11191201

11-19-2012

Allergan to acquire SkinMedica for $350 Million

Code: E11161201

11-15-2012

Reckitt Benckiser to commence tender offer for Schiff Nutrition

Code: E11151201

11-14-2012

Forest, Adamas announce licensing agreement

Code: E11141200

11-13-2012

PerkinElmer acquires Shanghai Haoyuan Biotech to complement screening capabilities

Code: E11131201

11-12-2012

Myrexis decides to dissolve and liquidate assets

Code: E11121201

11-12-2012

Biocryst ends $234.8 million Phase III flu trial in disapppointment

Code: E11091201

11-12-2012

Hepatitis C on the A-list for pharmas this week

Code: E11141201

11-12-2012

GSK work on malaria vaccine suffers setback

Code: E11141202

11-08-2012

Wellcome Trust, MRC kick off $20 million iPS initiative

Code: E11071201

11-08-2012

Sun Pharmaceutical acquires DUSA, gains dermatology platform

Code: E11081201

11-07-2012

Takeda America Holdings to acquire Envoy

Code: E11061201

11-05-2012

Life Technologies acquires Advanced Microscopy Group

Code: E11051201

11-05-2012

Universities in the United Kingdom to see $1.6 billion in science funding

Code: E11021201

11-01-2012

MRC to provide $11 million in funding for AstraZeneca compound research

Code: E10311201

11-01-2012

Vertex to test hepatitis C compounds with Janssen and GSK

Code: E11011201

10-31-2012

Bayer announces acquisition plans for Schiff Nutrition

Code: E10301201

10-29-2012

Menarini, Oxford BioTherapeutics forge $1 billion cancer deal

Code: E10291201

10-25-2012

McKesson acquires PSS World Medical

Code: E10251201

10-24-2012

Seattle Genetics, Abbott expand ADC agreement

Code: E10231201

10-24-2012

Shire, Fondazione Telethon ink research collaboration

Code: E10241200

10-23-2012

Pfizer to acquire NextWave Pharmaceuticals for as much as $680 million

Code: E10241201

10-23-2012

Genzyme and Alnylam enter into exclusive RNAi development and commercialization alliance

Code: E10241202

10-22-2012

Dr. Reddy's Laboratories to acquire OctoPlus for $36 million

Code: E10221201

10-22-2012

Novo Nordisk gets positive news from Europe regarding insulin drugs

Code: E10191201

10-18-2012

BioCryst to acquire Presidio Pharmaceuticals for $101 million

Code: E10181201

10-17-2012

Merck announces partnerships in antiviral, cardiovascular therapeutics

Code: E10161201

10-17-2012

Horizon, WUSTL establish Center of Excellence

Code: E10171201

10-16-2012

Life-science companies launch rare disease research competition

Code: E10161202

10-15-2012

PharmAria and Celgene announce strategic partnership

Code: E10151201

10-15-2012

Benitec Biopharma acquires Tacere Therapeutics for $1.5 million

Code: E10121201

10-11-2012

GSK, Aeras partner to develop tuberculosis vaccine

Code: E10111201

10-10-2012

Washington University to spearhead extensive Alzheimer's initiative

Code: E10101200

10-10-2012

Life Technologies brings Compendia into the fold

Code: E10091201

10-09-2012

AstraZeneca gains license for Ardelyx's NHE3 inhibitor program

Code: E10101201

10-09-2012

Takeda to acquire LigoCyte Pharmaceuticals for $60 million

Code: E10101202

10-08-2012

Optimer Pharmaceuticals to sell remaining ownership in Optimer Biotechnology for $60 million

Code: E10081201

10-08-2012

Mayne Pharma to acquire Metrics Inc. in deal worth as much as $120 million

Code: E10051201

10-04-2012

Partners to develop, commercialize agonist for gastroparesis

Code: E10031201

10-04-2012

Horizon, H3 Biomedicine kick off SyntheTx program

Code: E10041201

10-03-2012

Janssen, Astellas announce license agreement

Code: E10021201

10-01-2012

FDA approves Abbott Laboratories' Humira as ulcerative colitis therapy

Code: E10011201

09-28-2012

Teva purchases Huntington disease compound rights from NeuroSearch A/S

Code: 09271201

09-27-2012

European project to produce handheld malaria diagnosis device

Code: E09261200

09-26-2012

Medicago, PMP ink licensing agreement

Code: E09251201

09-25-2012

Complete Genomics Inc. to be acquired by Chinese firm BGI-Shenzhen for $117.6 million

Code: E09261201

09-25-2012

Valeant Pharmaceuticals acquires ophthalmic compound Visudyne for $112.5 million

Code: E09261202

09-24-2012

Peregrine stock price plunges on news of discrepanies in bavituximab trial

Code: E09241201

09-20-2012

Playing with DARTs

Code: E09201201

09-19-2012

Illumina lands FDA contract

Code: E09181201

09-19-2012

Baxter, Onconova ink licensing agreement

Code: E09191201

09-17-2012

Life Technologies to partner with Bristol-Myers Squibb for companion diagnostics development

Code: E09171201

09-17-2012

New NIH/NHGRI grants for harnessing nanoscale technologies to cut DNA sequencing costs

Code: E09141201

09-13-2012

Oncodesign announces Sanofi collaboration

Code: E09131201

09-12-2012

Vascular Pharmaceuticals, Janssen announce agreement

Code: E09121200

09-11-2012

GlaxoSmithKline opens research unit to study traditional Chinese medicine

Code: E09121201

09-11-2012

Merck Serono expands EGFR-targeted portfolio

Code: E09121202

09-11-2012

Pfizer to partner with Visterra

Code: E09111201

09-10-2012

Peregrine drug reportedly doubles lung cancer survival in trial

Code: E09101201

09-09-2012

SFJ Pharma to co-develop dacomitinib with Pfizer

Code: E09071201

09-06-2012

Entelos signs contract with FNIH for biomarker consortium

Code: E09051201

09-06-2012

Symphogen licenses EGFR antibody mixture to Merck

Code: E09061201

09-05-2012

Valeant nabs Medicis for $2.6 billion

Code: E09041201

08-31-2012

Janssen Biotech, Genmab sign potential $1 billion deal

Code: E08301201

08-30-2012

Sequenom completes distribution agreements

Code: E08281201

08-30-2012

Sunovion to acquire Elevation Pharmaceuticals

Code: E08291201

08-27-2012

Agilent acquires assets of Aurora

Code: E08271201

08-27-2012

Is the promise of emerging markets wishful thinking?

Code: E08241201

08-24-2012

Pfizer, Mylan to partner on generics in Japan

Code: E08231201

08-23-2012

Trangenomic seeks to develop early detection tools for pancreatic cancer

Code: E08221201

08-21-2012

GlaxoSmithKline drug halves attacks in hard-to-treat asthma

Code: E08221201

08-21-2012

A bidding war to come for Strides-owned injectables unit?

Code: E08221202

08-21-2012

Keeping an eye on DARPins

Code: E08211200

08-20-2012

Cinven acquires Mercury Pharma

Code: E08201201

08-20-2012

Mylan Pharmaceuticals gets FDA nod for generic Actos

Code: E08171201

08-16-2012

University of Utah receives $16 million NIH grant

Code: E08151201

08-16-2012

TG Therapeutics, Rhizen to collaborate on PI3K delta inhibitor

Code: E08161201

08-15-2012

GNS, CHDI to develop computer models of Huntington's

Code: E08141201

08-13-2012

Sun Pharmaceutical to take Taro Pharmaceutical private for $571 million

Code: E08131201

08-13-2012

Eli Lilly realizes $790 million in income from Amylin Pharmaceuticals

Code: E08101201

08-10-2012

Wellcome Trust, MRC to fund Cambridge stem cell center

Code: E08091201

08-09-2012

Synthetic Biologics, Intrexon launch second partnership

Code: E08081201

08-07-2012

Alzheimer’s drug gets boot by Pfizer and Johnson & Johnson after Phase III program failure

Code: E08071201

08-07-2012

Novartis gains immune-cell cancer therapy in deal with University of Pennsylvania

Code: E08081201

08-07-2012

FDA approves generic versions of Singulair

Code: E08081202

08-07-2012

Saladax enters into master collaboration agreement with Bristol-Myers Squibb

Code: E08061201

08-03-2012

NYGC announces launch of Innovation Center

Code: E08021201

08-02-2012

Alseres, Navidea team up for Parkinson’s diagnostic agent

Code: E08011201

07-31-2012

Cleveland BioLabs announces Russian contract agreement

Code: E07311201

07-31-2012

Pfizer terminates license to three products with Acura Pharmaceuticals

Code: E07301201

07-29-2012

Amarin Corp.'s fish oil drug wins FDA approval to treat high blood fat levels

Code: E07271201

07-27-2012

UWA, Agilent announce five-year collaboration

Code: E07261201

07-26-2012

University of Edinburgh, BGI announce MOU

Code: E07251201

07-25-2012

Forest, Almirall get green light for COPD treatment

Code: E07241201

07-24-2012

Chimerix signs worldwide license agreement with Merck & Co. for up to $168.5 million

Code: E07251201

07-24-2012

Fresenius Kabi AG acquires Fenwal

Code: E07251202

07-23-2012

Boehringer Ingelheim acquires Funxional Therapeutics’ FX125L compound

Code: E07231201

07-23-2012

FDA approves Onyx Pharmaceuticals' Kyprolis for multiple myeloma

Code: E07201201

07-21-2012

Amicus, GSK announce collaboration expansion

Code: E07191201

07-19-2012

Innophos acquires AMT Labs for $27 million

Code: E07181201

07-18-2012

Thermo Fisher to acquire One Lambda for $925 million

Code: E07171201

07-17-2012

GSK to acquire Human Genome Sciences for $14.25 per share in cash

Code: E07161201

07-13-2012

UC Davis, Agilent, FDA announce genome project

Code: E07121201

07-13-2012

Carl Zeiss licenses digital pathology patents from Olympus

Code: E07131201

07-12-2012

HemoShear, Expression Analysis announce partnership

Code: E07111200

07-09-2012

Luminex to acquire GenturaDx for $50 million

Code: E07091201

07-09-2012

Human Genome Sciences in the crosshairs

Code: E07061201

07-09-2012

Prokarium acquires oral vaccine technology from Emergent BioSolutions

Code: E07091202

07-09-2012

Janssen Pharmaceuticals enters alliance with CureBeta that could top $300 million in value

Code: E07111201

07-09-2012

ERT acquires invivodata

Code: E07111202

07-05-2012

Merck, MDxHealth expand collaboration

Code: E07051201

07-04-2012

Bristol-Myers Squibb to acquire Amylin Pharmaceuticals

Code: E07031201

07-02-2012

GSK settles healthcare fraud case for $3 billion

Code: E07021201

07-02-2012

Antibody deal struck for possible $500M-plus and neuromuscular deal for up to $271M

Code: E06291201

06-29-2012

KineMed receives $1.2 million from MJFF

Code: E06281201

06-28-2012

BioClinica, C.R. Bard win Microsoft award

Code: E06271200

06-27-2012

Pharma hit by additional layoffs

Code: E06261200

06-26-2012

EMA acts on alleged deficiencies in Roche’s reporting of medicines’ safety

Code: E06271201

06-26-2012

Compugen, Merck Serono to jointly establish biomarker company Neviah Genomics

Code: E06271202

06-25-2012

Pfizer and Bristol-Myers Squibb fail to win FDA approval for Eliquis

Code: E06251201

06-22-2012

Brisk week for the FDA

Code: E06211201

06-22-2012

Xanodyne Pharmaceuticals sells drug for $26 million to Depomed

Code: E06221201

06-20-2012

AstraZeneca, Rigel announce license agreement

Code: E06191201

06-20-2012

New collaboration heads Seaside

Code: E06201201

06-19-2012

AC Immune and Genentech enter into second antibody collaboration for Alzheimer’s disease

Code: E06181201

06-15-2012

Upsher-Smith to acquire Proximagen

Code: E06141201

06-15-2012

Valeant Pharmaceuticals to acquire OraPharma for $312 million

Code: E06151201

06-14-2012

Jazz Pharmaceuticals finalizes EUSA Pharma acquisition

Code: E06131200

06-13-2012

Hunting down Huntington's disease

Code: E06121201

06-11-2012

FDA approves Roche's Perjeta for people with HER2-positive metastatic breast cancer

Code: E06111201

06-11-2012

GlaxoSmithKline extends tender offer for Human Genome Sciences by three weeks

Code: E06081201

06-11-2012

Johnson & Johnson rumored to be paying as much as $2.2 billion to settle U.S. drug marketing charges

Code: E06131201

06-11-2012

GSK subsidiary pays $227 million for rights to Basilea Pharmaceutica eczema drug

Code: E06141202

06-07-2012

AFFiRiS AG takes Parkinson's vaccine to trials

Code: E06071201

06-07-2012

Estrogen compound seen to suppress tumor growth

Code: E06071202

06-06-2012

Baxter, Chatham partner on hemophilia treatments

Code: E06061201

06-05-2012

Genmab to partner with Novartis on antibodies

Code: E06051201

06-04-2012

A triple-play against cancer

Code: E06041201

06-04-2012

Forest gains access to antibacterial, sets up for possible acquisition

Code: E06011201

06-01-2012

PCGP announces release of 520 genome sequences

Code: E05311201

05-31-2012

City of Hope receives $5.2 million from CIRM

Code: E05301201

05-24-2012

NIH awards Lucigen $2.8 million SBIR grant

Code: E05231200

05-24-2012

GSK, AstraZeneca join others in antibiotic research program

Code: E05241201

05-22-2012

Agilent to acquire Danish company Dako for $2.2 billion

Code: E05231201

05-21-2012

iPierian advances monoclonal antibody drug development programs

Code: E05211201

05-21-2012

Osiris becomes trailblazer in stem cell therapy market with Prochymal approval

Code: E05181201

05-18-2012

HGS enacts 'poison pill' defense against GSK acquisition

Code: E05171201

05-17-2012

GSK to acquire Cellzome for $99 million

Code: E05161201

05-15-2012

Cornerstone, EKR Therapeutics ink definitive merger agreement

Code: E05151201

05-14-2012

Rib-X postpones initial public offering after cutting price in half

Code: E05111201

05-14-2012

OncoMed Pharma files for IPO

Code: E05141201

05-11-2012

Broad Institute, Fluidigm launch Single-Cell Genomics Center

Code: E05101201

05-09-2012

GSK takes acquisition offer to HGS shareholders

Code: E05091200

05-09-2012

Bayer Yakuhin, Santen announce co-promotion agreement

Code: E05081200

05-08-2012

Abbott pays big price to settle on Depakote

Code: E05081201

05-08-2012

Some Big Pharma players face uphill struggles

Code: E05081202

05-03-2012

Novartis to acquire Fougera Pharmaceuticals for $1.5 billion

Code: E05031201

05-02-2012

Multicenter partnership to sequence adenoviruses

Code: E05021201

05-01-2012

Novo Nordisk, Caisson Biotech announce license agreement

Code: E05011201

04-30-2012

Hologic to acquire Gen-Probe for $3.7 billion

Code: E04301201

04-27-2012

New acquisition to expand Amgen's presence in Turkey

Code: E04251201

04-27-2012

Jazz Pharmaceuticals buying EUSA Pharma for as much as $700 million

Code: E04271201

04-26-2012

Epizyme, Celgene announce strategic partnership

Code: E04261200

04-24-2012

AstraZeneca to acquire Ardea Biosciences for $1.26 billion

Code: E04251201

04-24-2012

After plan to acquire Illumina is scuttled, speculations begin on Roche next steps

Code: E04251202

04-24-2012

Bayer expands targeted cancer therapy collaboration with Amgen

Code: E04241200

04-23-2012

Nabi Biopharmaceuticals merges with Biota Holdings

Code: E04231201

04-20-2012

Aspen Phamacare buys GlaxoSmithKline OTC products for $263 million

Code: E04201201

04-20-2012

Human Genome Sciences turns down GSK's $2.6 billion offer

Code: E04191201

04-18-2012

Roche announces tender offer will not be extended

Code: E04181201

04-17-2012

Merck, Endocyte ink agreement for cancer drug candidate

Code: E04171201

04-13-2012

PhRMA reports $49.5 billion in R&D investment in 2011

Code: E04131201

04-12-2012

Synta, MMRC announce clinical trial for Hsp90 inhibitor

Code: E04121200

04-11-2012

Takeda to acquire URL Pharma for $800 million

Code: E04111200

04-10-2012

Mylan sues FDA to overturn Teva Pharmaceutical’s exclusivity for Provigil

Code: E04061201

04-10-2012

Optimer Pharmaceuticals shakes up leadership spots

Code: E04091201

04-10-2012

Affymax gets $50 million milestone in anemia deal with Takeda

Code: E04101201

04-10-2012

Do the winds favor Illumina in face-off with Roche?

Code: E04111201

04-10-2012

Amgen to pay $315 million for KAI Pharmaceuticals

Code: E04111202

04-05-2012

Roche: Illumina's fiduciary duties 'require engagement'

Code: E04041201

04-05-2012

Spectrum Pharmaceuticals to acquire Allos Therapeutics

Code: E04041202

04-03-2012

AstraZeneca, Amgen partner on monoclonal antibodies

Code: E04031201

04-02-2012

Forest Laboratories buys blood pressure drug Bystolic from Janssen Pharmaceutica for $357 million

Code: E04021201

04-02-2012

New Genentech breast cancer drug shows late stage trial success

Code: E03301201

03-29-2012

Roche increases offer price to approximately $6.7 billion

Code: E03291201

03-27-2012

Roche extends hostile acquisition offer yet again, Illumina continues to resist

Code: E03281201

03-27-2012

Shire to acquire FerroKin BioSciences for as much as $325 million

Code: E03281202

03-27-2012

Seeing eye to eye

Code: E03271201

03-26-2012

U.S. court dismisses AstraZeneca lawsuit against FDA

Code: E03261201

03-26-2012

Amylin and Lilly gets thumbs-up from European Union for new Byetta use

Code: E03231201

03-22-2012

New Index Ventures fund to support life sciences companies

Code: E03211201

03-22-2012

MSKCC, IBM partner on decision support system

Code: E03221201

03-20-2012

Roche files definitive proxy, sends letter to Illumina shareholders

Code: E03201201

03-20-2012

UCB, Oxford join forces in research collaboration

Code: E03201202

03-19-2012

Illumina continues to resist Roche takeover

Code: E03191201

03-16-2012

Shire to acquire FerroKin BioSciences for as much as $325 million

Code: E03161201

03-15-2012

Aeras granted $220 million from Gates Foundation

Code: E03151201

03-14-2012

Marina, ProNAi partner in exclusive license agreement

Code: E03141201

03-13-2012

AstraZeneca files lawsuit against FDA to delay generic competition

Code: E03141201

03-13-2012

Busy times for Pfizer

Code: E03141202

03-13-2012

Domain Therapeutics granted EUR 933,000 for schizophrenia work

Code: E03131200

03-12-2012

Bowel drug being studied by Tranzyme and Norgine fails to make the grade

Code: E03121201

03-09-2012

Promedior raises $21.5 million for fibrotic therapeutics

Code: E03081201

03-08-2012

Mersana, Endo to collaborate on ADC development

Code: E03071201

03-07-2012

Medicago, MTPC join forces in vaccine agreement

Code: E03061201

03-05-2012

Merck: Good news, bad news

Code: E03051201

03-05-2012

An end to the Farbrazyme shortage?

Code: E03021201

03-01-2012

Boston Biomedical Inc. to be acquired by DSP

Code: E03011201

02-29-2012

Enrollment completed for Phase III trial of GI motility drug

Code: E02291201

02-28-2012

Roche-Illumina saga continues with offer extension

Code: E02281201

02-27-2012

Procter & Gamble to cut 5,700 jobs and $10 billion

Code: E02241201

02-27-2012

Angiochem teams with GSK to discover and develop treatments of lysosomal storage diseases

Code: E02271201

02-23-2012

Collegium raises $22.5 million for chronic pain drug

Code: E02221200

02-23-2012

Genomma announces $834 million proposal to acquire Prestige

Code: E02231201

02-21-2012

Corralling Cushing's syndrome

Code: E02211200

02-20-2012

Gilead suffers setback with promising hepatitis C therapy

Code: E02201201

02-20-2012

Biogen Idec to acquire Stromedix in deal worth potentially more than $560 million

Code: E02221201

02-20-2012

PerkinElmer announces collaboration with Rutgers University

Code: E02221202

02-17-2012

NYGC initiative with Feinstein Institute to target Alzheimer's

Code: E02161201

02-16-2012

Celladon raises $43 million for heart failure treatment

Code: E02151201

02-14-2012

Biogen Idec acquires Stromedix for $75 million

Code: E02141201

02-13-2012

Valeant continues acquisition spree with agreement to snap up Eyetech Inc.

Code: E02131201

02-10-2012

FDA and HIV: A warning and a rejection this week

Code: E02101201

02-09-2012

Cytomedix snags Aldagen for $16 million in stock

Code: E02081200

02-09-2012

Celgene to invest $15 million in Acetylon

Code: E02091201

02-07-2012

ADC from A to Z

Code: E02081201

02-07-2012

Eli Lilly and Co. plans to freeze salaries for most employees in 2012

Code: E02081202

02-07-2012

Illumina rejects Roche proposal, decries offer as 'grossly inadequate'

Code: E02071200

02-05-2012

Merck KGaA signs cancer deal with Threshold Pharmaceuticals

Code: E02031201

02-02-2012

7,300 face layoffs as AstraZeneca announces restructuring program

Code: E02021201

02-01-2012

Roche prepares slate of board candidates for Illumina’s annual meeting

Code: E02011201

02-01-2012

ZFP technology forms basis of $13 million Sangamo, Shire agreement

Code: E02011202

01-31-2012

Organizations form global partnership to battle NTDs

Code: E01311201

01-30-2012

Valeant abandons effort to acquire ISTA

Code: E01301201

01-27-2012

Up and down: The A's and B's of staffing

Code: E01271201

01-27-2012

Round three ensues in hostile takeover attempt of Illumina by Roche

Code: E01271202

01-26-2012

Illumina announces stockholder rights agreement in wake of Roche proposal

Code: E01261201

01-25-2012

Roche tenders unsolicited $5.7 billion acquisition proposal for Illumina

Code: E01251200

01-24-2012

Watson Pharmaceuticals buys Ascent Pharmahealth Ltd. for $393 million

Code: E01251202

01-24-2012

EMD Millipore, Proteomics International to collaborate on diabetic nephropathy biomarkers

Code: E01241201

01-23-2012

Alnylam to slash workforce by a third

Code: E01201201

01-23-2012

Roche sets up co -marketing agreement with Unlibabs for greater access to HPV tests

Code: E01231201

01-23-2012

Lab21 acquires new real-time PCR technology

Code: E01231202

01-19-2012

Ventana lines up third recent companion diagnostic agreement

Code: E01191201

01-18-2012

Takeda announces workforce reductions of 2,800

Code: E01181201

01-17-2012

Epigenetics form epicenter of Genentech, Constellation agreement

Code: E01171201

01-17-2012

Novartis to restructure U.S. business and cut more than 1,900 jobs

Code: E011712

01-12-2012

NantWorks to acquire, redevelop former Indiana Pfizer plant

Code: E011201

01-11-2012

FORMA forms new oncology collaborations

Code: E01111200

01-10-2012

Janssen Pharmaceutica and Proteros expand relationship and enter into global agreement

Code: E01091201

01-10-2012

Plasticell to join Pfizer and University of Sheffield in a stem cell project led by Cellzome

Code: E01101201

01-10-2012

Bristol-Myers Squibb to acquire Inhibitex for $2.5 billion

Code: E01111201

01-10-2012

Sigma-Aldrich looks to buy BioReliance Corp. for $350 million in cash

Code: E01111202

01-09-2012

BDSI, Endo announce license agreement for pain treatment

Code: E01051201

01-04-2012

Biogen Idec, Isis announce SMA collaboration

Code: E01041201

01-03-2012

Accelrys nabs VelQuest for $35 million, strengthens paperless offerings

Code: E01031201

12-30-2011

Alexion to pay as much as $1 billion for Enobia

Code: E12291101

12-28-2011

Neuralstem secures FDA approval for Phase Ib MDD trial

Code: E12281101

12-28-2011

Zogenix, Astellas end co-promotion agreement early

Code: E12281102

12-26-2011

IBM makes massive research data available to public

Code: E12281101

12-26-2011

Pall aims for ForteBio to extend capabilities in $1B+ biopharma process monitoring market

Code: E12281102

12-22-2011

Takeda to acquire Intellikine for $190 million

Code: E12211101

12-22-2011

Merck licenses PI3K-delta inhibitor from Exelixis

Code: E12221101

12-20-2011

Amgen, Watson partner on (bio)similar interests

Code: E12201101

12-19-2011

Burrill & Co. launches life sciences venture fund with $313 million in commitments

Code: E12191101

12-19-2011

Pall Corp. to acquire ForteBio

Code: E12191102

12-18-2011

Valeant launches $327 million hostile bid for ISTA Pharmaceuticals

Code: E12161101

12-15-2011

Fanning the 'Embers' in metabolic research

Code: E12151101

12-14-2011

TGen, Karmanos to lead three-year melanoma study

Code: E12141100

12-13-2011

Abbott and Reata announce deal to develop and commercialize next-gen antioxidant inflammation modulators

Code: E12121101

12-13-2011

Geron abandons stem cell work and shifts to oncology focus

Code: E12141101

12-13-2011

Elsevier acquires Ariadne Genomics

Code: E12141102

12-13-2011

ddn announces 2011 iPad contest winner

Code: E12131101

12-13-2011

ImmusanT nets $20 million for treatment, diagnostic for celiac disease

Code: E12131102

12-08-2011

AstraZeneca acquires BeiKang Pharmaceutical Company Ltd.

Code: E12081101

12-07-2011

Theratechnologies to cut COPD program, 40 jobs

Code: E12071101

12-06-2011

Building on biosimilars

Code: E12061101

12-01-2011

MacroGenics, Servier announce a 'solid' agreement

Code: E12011101

11-30-2011

Affymetrix nabs eBioscience for $330 million

Code: E11301101

11-29-2011

Abbott expands companion Dx agreement with GSK to add test for additional investigational cancer immunotherapy antigen

Code: E11281101

11-29-2011

QIAGEN launches restructuring plan; 8% to 10% of workforce faces chopping block

Code: E11291102

11-29-2011

Roche to team up with PTC Therapeutics

Code: E11291101

11-22-2011

Valeant nabs iNova for approximately $689 million

Code: E11221101

11-21-2011

Geron discontinues stem cell work to focus on oncology

Code: E11231101

11-21-2011

Leica Microsystems acquires Labindia’s microscopy and histopathology divisions

Code: E11231102

11-21-2011

Gilead to acquire Pharmasset for $11 billion

Code: E11211101

11-18-2011

CureVac announces set of agreements with Sanofi Pasteur

Code: E11171101

11-18-2011

Medicis makes successful bid for Graceway assets

Code: E11181101

11-16-2011

ViroPharma completes DuoCort acquisition

Code: E11161101

11-15-2011

Geron announces end of stem cell programs

Code: E11151101

11-14-2011

FEI makes strategic life sciences tech acquisition by buying TILL Photonics

Code: E11141101

11-11-2011

Signum Biosciences, GSK announce collaboration

Code: E11111101

11-11-2011

Children’s Hospital Boston, Pfizer announce DMD agreement

Code: E11111102

11-09-2011

Teva to make up to 1,500 additional job cuts

Code: E11091101

11-08-2011

Pharmasset share price gets a boost after 100-percent cure rate in HCV trial

Code: E11091101

11-08-2011

NanoString nabs $20 million in a Series D round involving GE and former Genzyme CEO

Code: E11091102

11-08-2011

Amylin, Lilly terminate diabetes alliance

Code: E11081101

11-04-2011

GSK reaches investigation agreement with U.S. government

Code: E11041101

11-03-2011

Sanford-Burnham, Pfizer announce partnership

Code: E11021101

11-02-2011

Alnylam, GSK team up in new collaboration

Code: E11021101

11-02-2011

SurModics to offload pharmaceuticals subsidiary to Evonik

Code: E11021102

10-27-2011

Syk inhibitor focus of new Biogen, Portola collaboration

Code: E10271101

10-26-2011

Acton, Sanofi sign license agreement for allergy aerosol

Code: E10261101

10-25-2011

Cubist Pharmaceuticals to buy Adolor Corp. in potential $415 million deal

Code: E10241101

10-25-2011

Abbott does the two-step

Code: E10261101

10-25-2011

Novartis to lay off another 2,000 people

Code: E10261102

10-25-2011

Amgen announces $780 million charge for claims settlement

Code: E10251101

10-20-2011

Gladstone, Roddenberry Foundation open new stem cell center

Code: E10201101

10-18-2011

Les Laboratories Servier, miRagen sign new agreement

Code: E10181101

10-14-2011

A few hitches 'across the pond' for pharma products

Code: E10141101

10-13-2011

Amarantus closes Equity Funding Facility

Code: E10131101

10-12-2011

Bayer, Onyx Pharmaceuticals restructure Nexavar partnership

Code: E10121101

10-11-2011

FDA approves Merck’s Juvisync, the first combination drug to treat type 2 diabetes and high cholesterol in one tablet

Code: E10121101

10-11-2011

FDA approves Boehringer Ingelheim’s Combivent inhalation spray for the treatment of COPD

Code: E10121102

10-11-2011

GlycoMimetics, Pfizer sign $430 million license agreement

Code: E10111100

10-06-2011

Akorn to acquire certain assets from KDIL

Code: E10061101

10-04-2011

The Carlyle Group and Hellman & Friedman to acquire PPD for $3.9 billion

Code: E10041101

09-30-2011

Merck sells its interest in Johnson & Johnson-Merck Consumer Pharmaceuticals

Code: E09301101

09-28-2011

ddn launches Cancer Research Portal

Code: E09281106

09-27-2011

Valeant ups the ante in faceoff with Paladin to acquire Afexa

Code: E09281101

09-27-2011

RXi Pharmaceuticals plans to split into two public companies

Code: E09281102

09-27-2011

Novartis hands out 2,500 pink slips

Code: E09281103

09-27-2011

Biotie to acquire Newron in merger

Code: E09271101

09-23-2011

Week's staffing news reflects ups and downs

Code: E09231101

09-22-2011

Cardio3 BioSciences opens U.S. subsidiary

Code: E09221101

09-21-2011

Pacific Biosciences to cut loose 130 employees

Code: E09211101

09-20-2011

Jazz Pharmaceuticals, Azur Pharma to merge

Code: E09201101

09-15-2011

GE Healthcare to funnel $1 billion towards oncology efforts

Code: E09151101

09-14-2011

F-Star, Merck Serono ink inflammatory disease deal

Code: E09141100

09-13-2011

PerkinElmer to acquire Caliper Life Sciences for approximately $600 million

Code: E09141101

09-13-2011

Boehringer Ingelheim blood-thinning drug Pradaxa raises side effect concerns in New Zealand

Code: E09141102

09-13-2011

Eli Lilly launches NCD partnership program

Code: E09131101

09-12-2011

Breast cancer: A step forward for Nektar, a half-step back for Glaxo

Code: E09121101

09-08-2011

Elusys Therapeutics receives anti-toxin contract

Code: E09081101

09-07-2011

GSK awarded $94 million BARDA contract

Code: E09071101

09-01-2011

Pfizer extends tender offer to Icagen

Code: E09011101

08-31-2011

Ardelyx secures $30 million for clinical, preclinical candidates

Code: E08311101

08-30-2011

Valeant trumps Paladin's offer for Afexa

Code: E08301101

08-26-2011

Medivir subsidiary BioPhausia sells generics business for nearly $4.12 million

Code: E08261101

08-25-2011

Baxter to acquire Baxa Corporation for $380 million

Code: 08251101

08-24-2011

Afexa Board advises rejection of Paladin takeover bid

Code: 08241100

08-23-2011

Catalent Pharma Solutions to acquire Aptuit LLC's clinical trial supplies business for $410 Million

Code: E08241101

08-23-2011

GE Healthcare to acquire PAA Laboratories GmbH

Code: E08241102

08-23-2011

Series A round nets KalVista $13.2 million

Code: 08231101

08-22-2011

GlaxoSmithKline spins out hearing loss treatment company; investment companies show interest as well

Code: E08221101

08-19-2011

Forest Labs comes out on top in proxy struggle with Carl Icahn

Code: E08191101

08-18-2011

Roche, PerkinElmer ink new supply agreement

Code: E08181101

08-17-2011

Paladin Labs moves to acquire Labopharm Inc.

Code: E08171101

08-11-2011

Gilead, Tibotec combination HIV STR receives FDA approval

Code: E08111101

08-10-2011

Paladin Labs makes $50 million takeover bid for Afexa Life Sciences

Code: E08101101

08-10-2011

Array and Genentech enter into collaboration potentially worth more than $700 million

Code: E08101102

08-09-2011

Northern momentum

Code: E08101101

08-09-2011

In the land of the frowning sun

Code: E08101102

08-09-2011

Pfizer partners with UC San Diego in five-year deal worth as much as $50 million

Code: E08091101

08-03-2011

New Celgene, Acceleron agreement to target anemia

Code: E08031101

08-02-2011

Merck announces 13,000 employees to be let go by 2015

Code: E08021101

08-01-2011

Shionogi to acquire China's C&O Pharmaceutical Technology for $181.9M

Code: E08011101

07-28-2011

Brooks closes $79 million Nexus acquisition

Code: E07281101

07-28-2011

Baxter Ventures formed to invest in early-stage companies

Code: E07281102

07-27-2011

Sherley, et. al., v. Sebelius, et al. lawsuit dropped

Code: E07271100

07-26-2011

Bristol-Myers Squibb to pay as much as $475 million for Amira

Code: E07271101

07-26-2011

FDA rejects new use for Johnson & Johnson immune disorder drug

Code: E07271102

07-26-2011

OraSure to acquire DNA Genotek for $53 million

Code: E07261101

07-21-2011

AstraZeneca's heart drug gets nod from FDA

07-20-2011

Allos, AMAG see straight A's in merger deal

Code: E07201101

07-19-2011

Allergan to acquire Vicept for up to $275 million

Code: E07191101

07-18-2011

Shionogi signs possible $127M deal to expand portfolio with nine Victory Pharma products

Code: E07181101

07-14-2011

Bristol-Myers Squibb’s YERVOY nets EU approval

Code: E07141101

07-13-2011

INC Research acquires Kendle for $232 million

Code: E07131100

07-12-2011

Sanofi sells dermatology unit to Valeant Pharmaceuticals for $425 million

Code: E07131101

07-12-2011

Pfizer plans to sell or spin off two business units, causing stir among analysts

Code: E07131102

07-12-2011

Zogenix, DURECT agreement aims at getting under patients’ skin

Code: E07121101

07-11-2011

Micromet cancer drug deal with Amgen worth as much as $1 billion

Code: E07111101

07-08-2011

Baxter International and Halozyme Therapeutics release Phase III study data for HyQ

Code: E07081101

07-07-2011

BMS, Innate Pharma partner in immuno-oncology agreement

Code: E07071101

07-06-2011

Sanofi, Rib-X ink deal to seek antibiotics for multi-drug resistant pathogens

Code: E07061101

07-05-2011

Janssen DVT drug gets FDA nod

Code: E07051101

07-01-2011

Prosidion DPP-IV patent estate sold to Royalty Pharma

Code: E07011101

06-29-2011

AstraZeneca, PTC Therapeutics team up in research collaboration

Code: E06291101

06-28-2011

Tibotec, Gilead hash out HIV drug agreements

Code: E06281101

06-23-2011

BioMarin acquires Cork-based manufacturing plant from Pfizer for $48.5 million

Code: E06231101

06-22-2011

Luminex acquires EraGen for $34 million

Code: E06221100

06-21-2011

Endo Pharmaceuticals completes $2.9 billion acquisition of American Medical Systems

Code: E06221101

06-21-2011

Stem cell research survey initiated by ddn and Mizuho

Code: E06221102

06-21-2011

BYDUREON secures approval across the pond

Code: E06211101

06-17-2011

K-V Pharmaceutical to divest generics business to Zydus for $60 million

Code: E06171102

06-16-2011

Boehringer Ingelheim, Zealand Pharma deal with diabetes

Code: E06161101

06-15-2011

Adolor, GSK enter into agreement over ENTEREG

Code: E06151101

06-14-2011

GSK acquires equity interest in joint venture company from Shenzhen Neptunus

Code: E06141101

06-13-2011

Synageva BioPharma to merge with Trimeris Inc. in all-stock deal

Code: E06131101

06-10-2011

Synthes enters collaboration with Eli Lilly on orthopedic products

Code: E06101101

06-09-2011

Pfizer opens Boston Centers for Therapeutic Innovation

Code: E06091101

06-07-2011

South Carolina delivers serious blow to Johnson & Johnson over Risperdal

Code: E06081102

06-07-2011

Making some mayhem for melanoma

Code: E06081101

06-07-2011

Roche, Merck form diagnostics collaboration

Code: E06071101

06-06-2011

Ligand and The Medicines Company reach license deal for Captisol-enabled IV formulation of clopidogrel

Code: E06061101

06-03-2011

Johnson & Johnson backs away from diabetes drug; returns rights to Diamyd

Code: E06031101

06-02-2011

Bristol-Myers Squibb, Roche collaboration to combine metastatic melanoma treatments

Code: E06021101

06-01-2011

Evotec acquires Compound Focus, Inc. for approximately $14.7 million

Code: E06011101

05-31-2011

AVEO, Centocor ink license agreement to develop, commercialize anti-RON antibodies

Code: E05311101

05-25-2011

Watson acquires Specifar for $562 million

Code: E05250100

05-24-2011

Pfizer gets trio of positive reactions

Code: E05251101

05-24-2011

Multiplex makes for a magnetic attraction

Code: E05251102

05-24-2011

CASE STUDY: Increasing access for medicinal chemists with LAB2LAB

Code: E05251103

05-24-2011

Cilag GmbH to acquire J.B. Chemicals’ Russian OTC brands

Code: E05241101

05-24-2011

AstraZeneca, Daiichi Sankyo enter into co-promotion agreement

Code: E05241101

05-23-2011

Par Pharmaceutical to acquire Edict Pharmaceuticals for as much as $37.6 million

Code: E05231101

05-19-2011

Takeda seals the deal on Nycomed

Code: E05191101

05-19-2011

Thermo Fisher acquires Phadia for approximately $3.5 billion

Code: E05191102

05-18-2011

Shire to acquire Advanced BioHealing for $750 million

Code: E05181101

05-17-2011

Merck secures approval, debuts new hepatitis C drug

Code: E05171101

05-13-2011

Analysts abuzz over rumors that Takeda may acquire Nycomed

Code: E05131101

05-12-2011

Bioanalytical Systems nets $4.7 million in public offering

Code: E05121101

05-11-2011

Allos, Mundipharma to collaborate on FOLOTYN development

Code: E05110100

05-10-2011

C’est la vie! Sanofi-aventis alters name and refines strategic game

Code: E05111102

05-10-2011

Alkermes and Elan Drug Technologies to merge in $960 million deal

Code: E05111101

05-10-2011

The ‘GIST’ of things: Bayer’s investigational drug on FDA Fast Track

Code: E05101101

05-09-2011

Immunologix and Davospharma enter strategic alliance

Code: E05091101

05-06-2011

Parting ways with asthma and diabetes

Code: E05061101

05-05-2011

INC Research holds a candle for Kendle

Code: E05051101

05-04-2011

Molecular Partners, Allergan license agreement a sight for sore eyes

Code: E05041101

05-04-2011

New collaboration to focus on the ABCs of ETBs

Code: E05041102

05-03-2011

Diabetes drug gets thumbs-up from FDA

Code: E05031101

05-02-2011

Teva to acquire Cephalon for $6.8 billion

Code: E05021101

05-02-2011

Court lifts ban on stem cell research funding

Code: E05021102

04-29-2011

Researchers at Scripps create new genetic model of premature aging diseases

Code: E04291101

04-28-2011

OncoMed IND gains FDA approval to initiate Phase I clinical trials

Code: E04281101

04-28-2011

Merck’s hepatitis C treatment secures unanimous FDA panel approval

Code: E04281102

04-27-2011

Johnson & Johnson to acquire Synthes for $21.6 billion

Code: E04271100

04-26-2011

Merck and QIAGEN team up to improve access to cervical cancer vaccination in developing countries

Code: E04271102

04-26-2011

FDA grants approval to sanofi-aventis for Menactra meningococcal conjugate vaccine use in infants

Code: E04271101

04-26-2011

U.K. government deploys ‘Plan for Growth’

Code: E04271105

04-26-2011

FDA panel to consider new hepatitis C drug candidate from Merck

Code: E04261101

04-25-2011

KemPharm and MonoSol Rx to co-develop and commercialize novel ADHD prodrug

Code: E04251101

04-22-2011

Daiichi Sankyo receives first market approval in Japan for Lixiana (edoxaban)

Code: E04221101

04-21-2011

Merck, Sanofi Pasteur combination vaccine moves to Phase III trials

Code: E04211101

04-20-2011

FDA grants approval for Rituxan in treatment of two orphan diseases

Code: E04201101

04-19-2011

Baxter International, Prism Pharmaceuticals enter into definitive merger agreement

Code: E04191101

04-18-2011

FDA triple play roundup: An approval, a denial and a response

Code: E04181101

04-14-2011

Regulus Therapeutics, UC San Diego collaborate on microRNA-targeted therapies

Code: E04141101

04-13-2011

FDA panel votes 8-2 in favor of Pfizer drug for pancreatic neuroendocrine tumors

Code: E04131101

04-12-2011

New study examines cost savings, chemoprevention aspects of tamoxifen

Code: E04131102

04-12-2011

Merck and Sun Pharmaceutical form joint venture around branded generic drugs in emerging markets

Code: E04131103

04-12-2011

Coupling their efforts on promising G-protein coupled receptor

Code: E04131104

04-12-2011

Johnson & Johnson pays $78 million to settle bribery and kickback charges in the U.S. and U.K.

Code: E04131105

04-12-2011

Medivir to acquire BioPhausia for about $90 million

Code: E04121101

04-11-2011

Amgen looks to Brazil for some growth

Code: E04111102

04-07-2011

AstraZeneca gains FDA approval for medullary thyroid cancer drug

Code: E04071101

04-06-2011

Cephalon rejects Valeant’s $5.7 billion takeover bid

Code: E04061101

04-05-2011

Boehringer Ingeleim’s Viramune XR receives FDA approval

Code: E04051101

04-05-2011

Merck’s acquisition of Inspire to total $430 million

Code: E04051102

04-04-2011

Pfizer to sell Capsugel business to KKR for nearly $2.4 billion

Code: E04041101

03-31-2011

FDA grants Fast Track designation to Nile’s cenderitide

Code: E03311101

03-30-2011

Gilead, Yale collaboration to target novel cancer therapies

Code: E03301101

03-29-2011

Cephalon announces ChemGenex takeover bid

Code: E03291101

03-28-2011

New melanoma drug from BMS gets approval from FDA

Code: E03281101

03-25-2011

Bellicum Pharmaceuticals receives $5.7M commercialization award from CPRIT

Code: E03251101

03-24-2011

Champions Biotechnology, Cephalon initiate technology collaboration

Code: E03241101

03-23-2011

sanofi-aventis issues $7 billion worth of notes in debt sale

Code: E03231105

03-22-2011

Almac and Exco InTouch form alliance to deliver patient compliance and ePRO services using multiple technologies

Code: E03211101

03-22-2011

Cephalon to purchase all Gemin X outstanding capital stock for $225 million

Code: E03221101

03-21-2011

Gilyena gets a thumbs-up in Europe to go along with U.S. approval

Code: E03231102

03-21-2011

Quest Diagnostics to acquire Celera

Code: E03231101

03-17-2011

Genfit, sanofi-aventis form research collaboration

Code: E03171101

03-16-2011

A cautious approach in Amylin-Takeda obesity trial

Code: E03161101

03-15-2011

Bayer’s MRI contrast agent secures FDA approval

Code: E03151101

03-14-2011

Omthera Pharmaceuticals raises $33.9 million in Series B funding led by New Enterprise Associates

Code: E03141101

03-11-2011

Not a bulls-eye, but some good results for aflibercept for NSCLC

Code: E03111101

03-10-2011

Benlysta approval marks arrival of first new treatment for systemic lupus in a half-century

Code: E03101101

03-08-2011

Unloading Organon operations is too costly and complex, Merck reports

Code: E03091102

03-08-2011

Knocking it out of the park in the human genome

Code: E03091101

03-07-2011

AstraZeneca and Galderma Pharma enter into R&D collaboration to develop new treatments for dermatological diseases

Code: E03071101

03-01-2011

Agilent Technologies acquires BIOCIUS Life Sciences and Lab901

Code: E03011101

02-22-2011

Forest Laboratories to acquire Clinical Data for $1.2 billion

Code: E02231101

02-22-2011

Diabetes pipeline cannot reverse cardiovascular and metabolic market decline

Code: E02231102

02-22-2011

IBM and Nuance to bring IBM’s “Watson” analytics technology to personalized medicine arena

Code: E02231103

02-18-2011

AstraZeneca pays out another big chunk of cash for Seroquel claims

Code: E02181101

02-16-2011

sanofi-aventis to buy Genzyme Corp. for $20.1 billion

Code: E02161101

02-15-2011

Talecris shareholders give nod to merger with Grifols

Code: E02151101

02-08-2011

GenomeQuest and INRIA collaborate on genome mapping technology for multi-genome analysis

Code: E02091101

02-08-2011

Optimer Pharmaceuticals and Astellas Pharma sign collaboration for new antibiotic compound

Code: E02091102

02-01-2011

Valeant Pharmaceuticals to acquire PharmaSwiss S.A. for $481 million

Code: E02011101

01-31-2011

Alexion Pharmaceuticals acquires Taligen Therapeutics for $111 million

Code: E01311101

01-25-2011

Sanford-Burnham inks deal with J&J to discover medicines for Alzheimer’s Disease and neuropsychiatric disorders

Code: E01261101

01-25-2011

Novartis seeks to acquire Genoptix for $470 million in all-cash offer

Code: E01261102

01-25-2011

PerkinElmer launches next-generation DNA sequencing and analysis services

Code: E01261103

01-20-2011

Bad news for branded pharma? Datamonitor predicts slow going through 2015

Code: E01201101

01-19-2011

Theraclone and Pfizer enter into infectious disease and cancer antibody discovery collaboration

Code: E01191101

01-17-2011

Domain Therapeutics and Merck Serono to develop drugs for Parkinson’s Disease

Code: E01171101

01-13-2011

Doesn’t look good for Eli Lilly’s liprotamase pancreatic-enzyme replacement therapy

Code: E01131101

01-13-2011

UCSF scores two R&D collaboration deals with sanofi-aventis

Code: E01131102

01-10-2011

Genzyme and sanofi-aventis engaging in direct talks about acquisition

Code: E01121101

01-10-2011

Epizyme announces strategic alliance with GSK to develop epigenetic therapeutics

Code: E01121102

01-10-2011

Ardea Biosciences earns $15 million clinical milestone payment from Bayer HealthCare

Code: E01121103

01-04-2011

Santaris Pharma announces expanded worldwide strategic alliance with Pfizer

Code: E01041101

01-04-2011

ddn announces 2010 iPad contest winner

Code: E01041102

12-31-2010

Sigma-Aldrich acquires Cerilliant Corp.

Code: E12311001

12-30-2010

FDA puts brakes on experimental pain drug tests

Code: E12311002

12-29-2010

Sanford-Burnham, Takeda and Florida Hospital announce obesity partnership

Code: E12281001

12-27-2010

Double-whammy dyslipidemia drug Certriad abandoned by Abbott and AstraZeneca

Code: E12271001

12-20-2010

Cancer drug deal between sanofi-aventis and Avila Therapeutics potentially worth more than $800 million

Code: E12201001

12-20-2010

Gilead Sciences to acquire Arresto BioSciences for $225 million

Code: E12201002

12-17-2010

Pfizer extends $3.6 billion tender offer to acquire King Pharmaceuticals

Code: E12201001

12-17-2010

Novartis moves forward with acquisition of Alcon for $12.9 billion

Code: E12201002

12-17-2010

GSK and Impax enter deal for late-stage Parkinson’s disease compound

Code: E12201003

12-14-2010

Trophos to lead new MitoCare consortium

Code: E12141001

12-07-2010

Compugen licenses novel oncology target to Seattle Genetics

Code: E12071001

12-07-2010

True relief with sustained release for largely unmet neurological problem

Code: E12071002

12-07-2010

GSK to acquire Nanjing MeiRui Pharmaceuticals in China

Code: E12071003

12-07-2010

Pfizer's bosutinib fails to meet primary endpoint in Phase III study for chronic myeloid leukemia

Code: E12071004

12-01-2010

GI-oriented company Axcan Holdings to buy out specialty pharma Eurand for $583M

Code: E12011002

11-30-2010

Clinical Data to sell testing unit to Transgenomic for $15.4 million

Code: E11301001

11-29-2010

Amarin stocks up on promising news of new lipid-lowering drug

Code: E11291001

11-22-2010

Sigma announces the addition of new Prestige Antibodies powered by Atlas Antibodies, bringing total to over 10,000

Code: E11221001

11-22-2010

Johnson & Johnson and Takeda units recall batches of Velcade on reports of impurities

Code: E11231003

11-21-2010

Roche announces plans to restructure and cut 6 percent of workforce over two years

Code: E11231001

11-21-2010

Bristol-Myers Squibb and Pfizer end study on anti-clotting drug due to bleeding

Code: E11231002

11-17-2010

UCSF and Optivia collaborate to predict liver toxicity in drugs development process

Code: E11161001

11-09-2010

Eli Lilly to acquire Avid Radiopharmaceuticals

Code: E11101003

11-09-2010

Sigma Life Science collaborates with The Jackson Laboratory for distribution of genetically engineered mice

Code: E11101004

11-02-2010

Nycomed buys majority stake in Chinese firm Guangdong Techpool Bio-Pharma for $210 million

Code: E11021001

10-29-2010

Astra Zeneca takes big hit to profit in third quarter

Code: E10281001

10-25-2010

Getting personal

Code: E10271001

10-25-2010

Sanofi Pasteur making progress on two fronts with Fluzone

Code: E10271002

10-25-2010

Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement

Code: E10271003

10-25-2010

Essentialis receives agreement from the FDA for Phase III trial of DCCR

Code: E10251001

10-21-2010

Caliper Life Sciences signs co-marketing pact with Illumina to improve sequencing workflows

Code: E10211001

10-14-2010

Fate and BD advance broad availability of stem cells

Code: E10141001

10-11-2010

Paying big to source out R&D as part of corporate transformation

Code: E10131001

10-11-2010

Genzyme continues to spurn offer as sanofi-aventis goes hostile

Code: E10131002

10-11-2010

Novartis willing to pay to play with Gilenya

Code: E10131003

10-08-2010

Hostile intent: sanofi-aventis’s play for Genzyme heats up

Code: E10081001

10-07-2010

Watson throws $30M in the pot as it and Moksha8 form marketing partnership for Brazil and Mexico

Code: E10071002

10-04-2010

ProteoTech and Tasly Pharmaceuticals announce Alzheimer’s disease drug development agreement for Exebryl-1

Code: E10041001

10-01-2010

Recipharm AB acquires Abbott manufacturing site in Spain

Code: E10011001

09-30-2010

Covance becomes sanofi-aventis’ R&D Partner as part of $2.2 billion agreement

Code: E09301001

09-28-2010

Trophos initiates clinical development for novel cardioprotective compound

Code: E09281001

09-27-2010

OpGen completes $17 million Series B financing

Code: E09271001

09-22-2010

GSK files suit against Roche over claims that Herceptin infringes patents

Code: E09221006

09-20-2010

Getting interactive at ddn with new blog

Code: E09221003

09-20-2010

Analysts, investors weigh in on Johnson & Johnson acquisition of Crucell

Code: E09221001

09-20-2010

Recent Genzyme actions may set it up well for sanofi acquisition

Code: E09221002

09-17-2010

Johnson & Johnson sets its sights on full ownership of Crucell

Code: E09171001

09-15-2010

Diaceutics and London Genetics partner to accelerate biomarker development in the global biopharmaceutical industry

Code: E09151001

09-13-2010

Genzyme sells business unit to LabCorp and announces upcoming cuts

Code: E09131001

09-07-2010

One less potential rival for Genzyme’s affections?

Code: E09081001

09-07-2010

Roche goes route of reduction

Code: E09081002

09-01-2010

Abbott receives FDA Approval for hepatitis B assay

Code: E09011001

08-26-2010

Pharmasset initiates Phase IIb clinical trial of PSI-7977 for chronic hepatitis C

Code: E08251001

08-23-2010

Life Technologies to acquire Ion Torrent for $375 million

Code: E08251001

08-23-2010

South Africa's Aspen to buy drug business of Australia's Sigma $804 million

Code: E08251002

08-20-2010

ImmunoGen receives orphan drug designation for lorvotuzumab mertansine intreatment of small-cell lung cancer

Code: E08191001

08-17-2010

Xenon initiates a Phase II clinical trial in post herpetic neuralgia for topical XEN402

Code: E08171001

08-16-2010

Pacific Biosciences swims out into IPO waters

Code: E08161001

08-11-2010

Scripps scientists suggest new avenue for treating epileptic seizures

Code: E08111002

08-11-2010

A window into the liver

Code: E08111003

08-10-2010

The future is now

Code: E08111001

08-10-2010

Hands across the water: Schiff and PDS make cross-Atlantic alliance

Code: E08101001

08-06-2010

PerkinElmer acquires VisEn Medical Inc.

Code: E08061001

08-02-2010

Complete Genomics files for proposed $86.3 million initial public offering

Code: E08021001

07-29-2010

Trophos publishes the identification and characterization of novel cardioprotective compound

Code: E07291001

07-27-2010

NovImmune enters exclusive antibody licensing agreement with Genentech

Code: E07271001

07-27-2010

AbD Serotec secures exclusive worldwide license to key diagnostic antibody

Code: E07271002

07-27-2010

Affymetrix releases data from validated SNP database for design of custom genotyping arrays

Code: E07271003

07-26-2010

Rumors fly of huge sanofi-aventis U.S. acquisition brewing

Code: E07281001

07-26-2010

Mylan to pay $550 million in cash for Irish drug firm Bioniche

Code: E07281002

07-26-2010

Thermo Fisher Scientific announces collaboration to establish new Tokyo Biomarker Research Center

Code: E07261001

07-21-2010

Actelion obtains option to acquire privately-held Trophos

Code: E07201001

07-21-2010

Meridian Bioscience completes acquisition of Bioline group of companies

Code: E07211001

07-19-2010

NEXUS Biosystems acquires Tecan’s REMP sample management business

Code: E07191001

07-16-2010

Avandia dodges bullet, but still takes some flak

Code: E07161001

07-12-2010

Supreme Court patent ruling on Bilski means much for diagnostics, less for pharma

Code: E07141001

07-12-2010

UK’s NICE agency decides not to play so nice with Roche and Takeda

Code: E07141002

07-12-2010

Siemens sues Enzo over patent on nucleic acid hybridization assay technology

Code: E07121001

07-09-2010

Strativa Phamaceuticals becomes a groundbreaking “filmmaker”

Code: E07091001

July 2010

A step up for systems biology

Code: E071006

07-07-2010

Roche and IBM collaborate to develop “bar code reader”-style DNA sequencing technology

Code: E07071001

07-06-2010

Eli Lilly to buy drug developer Alnara Pharmaceuticals

Code: E07061001

06-30-2010

Celsis seeks injunction against Invitrogen regarding LiverPool patent

Code: E06301001

06-29-2010

Bon voyage to the flu vaccine business for Abbott?

Code: E06301001

06-28-2010

Aeterna Zentaris teams up with Almac to develop therapy and companion diagnostic in cancer

Code: E06281001

06-25-2010

Thermo Fisher Scientific wins Microsoft Life Sciences Innovation Award for third consecutive year

Code: E06251001

06-25-2010

Symyx and Certara: When more money isn’t enough

Code: E06251001

06-20-2010

Abbott prepares to acquire Piramal’s Healthcare Solutions business and capture top pharma spot in India

Code: E06231001

06-20-2010

Medicare decision may have serious repercussions for RedPath acquisition

Code: E06231002

06-16-2010

City of Hope leads first successful use of RNA interference to treat HIV infection

Code: E06161001

06-15-2010

BioClinica aims to simplify the handling of clinical trial data with platform connected to MS apps

Code: E06141001

06-11-2010

BioTime forms new subsidiary, OrthoCyte, to develop treatments for orthopedic conditions using stem cell technology

Code: E06101001

06-08-2010

Forest Labs and TransTech Pharma enter into deal valued at over $1 billion potentially

Code: E06081001

06-07-2010

Grifols to acquire Talecris Biotherapeutics for around $3.4 billion

Code: E06091001

06-07-2010

Lilly and Merck suffer a bit of a setback with disappointing Erbitux results

Code: E06091002

06-07-2010

Exiqon plans to close down operations at Oncotech Inc.

Code: E06091003

06-07-2010

Skin cancer drug news gives boost to BMS shares

Code: E06071001

06-04-2010

Life Technologies announces Genomic Cancer Care Alliance

Code: E06041001

06-02-2010

City of Hope receives FDA approval for human neural stem cell clinical trial

Code: E06021001

06-01-2010

CombiMatrix to cease M&A activities

Code: E06011001

05-25-2010

Clovis Oncology and Avila Therapeutics sign $209 million partnership

Code: E05251001

05-24-2010

Quest Diagnostics gets FDA clearance for molecular diagnostics-based H1N1 test

Code: E05241001

05-24-2010

FDA fines Genzyme Corp. $175 million for manufacturing problems

Code: 05241002

05-24-2010

Astellas Pharma finally woos OSI Pharmaceuticals with $4 billion offer

Code: E05261001

05-24-2010

Life Technologies teams with EdgeBio and Virginia Commonwealth University in schizophrenia marker study

Code: E05261002

05-20-2010

Roche Diagnostics and ACC collaborate on development of Web-based clinical resource on biomarkers

Code: E05201001

05-19-2010

Caliper gets $2.9 million contract from EPA

Code: E05191001

05-18-2010

Pfizer looking at around 6,000 job cuts in plant network reconfiguration

Code: E05181001

05-17-2010

Astellas finally convinces OSI Pharmaceuticals to agree to merger after raising offer to $4 billion

Code: E05171001

05-14-2010

Series B financing round nets caprotec bioanalytics just over $5 million

Code: E05141001

05-13-2010

Celsis reaches settlement agreement with XenoTech over CryoXTreme

Code: E05131002

05-13-2010

GE Healthcare and CardioDx Form Alliance

Code: E05131001

05-12-2010

Takeda plans to cut nearly 2,000 jobs

Code: E05121000

05-11-2010

SBS and ALA: Together at last...almost

Code: E05121001

05-11-2010

ARIAD restructures its ridaforolimus collaboration with Merck

Code: E05121002

05-11-2010

J&J subsidiary shuts down plant in wake of children’s medicine recall

Code: E05121003

05-06-2010

NHGRI uses new sequencing strategies to rapidly pinpoint causes of rare inherited illnesses

Code: E05061001

05-05-2010

Life sciences employment has weathered recession fairly well

Code: E05051001

05-04-2010

Colorado State University biochemists receive $7.8M grant to study how chromosomes “unravel” genetic info

Code: E05041001

05-03-2010

Department of Energy announces upgrade plan for Advanced Photon Source

Code: E05031001

04-29-2010

Scripps gets some serious scrip with $1.3 million NIH grant

Code: E04291001

04-28-2010

CombiMatrix and Merck both plan some cutting

Code: E04281005

04-27-2010

Cellular Dynamics Raises $40.6 million

Code: E04271001

04-26-2010

Logical hoping for results patients can stomach on Phase IIb study of analgesic

Code: E04261001

04-26-2010

Oracle buys Phase Forward

Code: E04281001

04-26-2010

Novartis exercises right to purchase nearly $1 million in Alnylam stock

Code: E04281002

04-22-2010

NASDAQ halts trading in Acura Pharmaceuticals stock

Code: E04221001

04-20-2010

CombiMatrix looks toward strategic and operational restructuring

Code: E04201001

04-19-2010

Elan ponders value of spinning off its drug discovery unit

Code: E04191001

04-16-2010

Thermo Fisher Scientific acquires Proxeon

Code: E04151001

04-16-2010

OpenHelix partners with Protein Data Bank

Code: E04151002

04-12-2010

Accelrys, Symyx agree to informerger

Code: E04141001

04-12-2010

Pfizer has eye on Asian diseases for foothold in Asia

Code: E04141002

04-12-2010

Life Technologies takes majority stake in GeneArt

Code: E04141003

04-08-2010

Roche NimbleGen commits to GMP and FDA submission for microarrays

Code: E04081001

04-07-2010

Alimera Sciences files for $87 million IPO

Code: E04071001

04-05-2010

Accelrys and Symyx announce merger of equals

Code: E04051001

04-01-2010

AMAG Pharmaceuticals enters into anemia drug licensing deal with Takeda

Code: E04011001

03-30-2010

CellMax enters the “final frontier”

Code: E03301001

03-29-2010

Ranbaxy and Pfenex team up to develop a biosimilar therapeutic protein

Code: E03291001

03-26-2010

Luminex makes an Australian acquisition and a North Carolina collaboration deal

Code: E03261001

03-24-2010

Aureus Pharma participating in European Biointelligence R&D program

Code: E03241001

03-22-2010

FDA requests complete response regarding new diabetes drug

Code: E03241002

03-22-2010

Teva snatches Ratiopharm away from Pfizer and Actavis with nearly $5B offer

Code: E03241001

03-18-2010

NHGRI launches genomic careers resource for students

Code: E03181001

03-16-2010

Eli Lilly gets rights to sell testosterone drug in deal worth up to $335M

Code: E03161001

03-15-2010

ALA and SBS propose to merge as SLAS

Code: E03151001

03-11-2010

Abbott to acquire Facet Biotech and boost early- and mid-stage pipelines

Code: E03111001

03-08-2010

Merck to acquire Millipore for $7.2 billion

Code: E03101001

03-08-2010

Life Technologies, TGen and US Oncology partner on “groundbreaking” breast cancer sequencing research

Code: E03101002

03-08-2010

Divestiture of MDS Pharma Services now complete

Code: E03081001

03-04-2010

Pfizer may put in bid of $4 billion to acquire Ratiopharm

Code: E03031001

03-01-2010

Imperial Innovations Group plc leads £5.6M funding round in Myotec Therapeutics

Code: E03011001

02-28-2010

Lilly and Covance form strategic alliance they call a “win-win” for themselves and patients

Code: E02281001

02-22-2010

CellCentric heads new collaboration with Sigma-Aldrich and TAP

Code: E02241002

02-22-2010

Abbott completes acquisition of Solvay Pharmaceuticals, eases EU antitrust concerns

Code: E02241001

02-19-2010

Gentel Biosciences powers protein research with new Proteomics Multi-System

Code: E02191001

02-18-2010

AB SCIEX acquires Eksigent liquid chromatography business

Code: E02181001

02-17-2010

PerkinElmer launches health screening lab in India, partners with MediScan Systems

Code: E02171001

02-16-2010

IBM Research collaborates with Australian Institutions to push boundaries of medical research

Code: E02161001

02-12-2010

RTS Acquires Hatch Science

Code: E02111001

02-11-2010

MDS Pharma Services seems set to have new ownership

Code: E02111001

02-08-2010

Cellular Dynamics launches human iPSC-derived cardiomyocytes

Code: E02101001

02-08-2010

BioMarin Pharmaceutical to acquire Lead Therapeutics

Code: E02101002

02-08-2010

Hamilton Robotics Validates Artel MVS on MICROLAB STAR and NIMBUS

Code: 02091001

02-05-2010

Teva announces 'settlement in principle' regarding drug pricing lawsuits

Code: E02051001

February 2010

Show Preview: 49th Annual Meeting and ToxExpo of the Society of Toxicology

Code: E02041001

02-03-2010

Call for Entries for Eppendorf & Science Prize for Neurobiology

02-01-2010

Cephalon Inc. to acquire Mepha AG for $590 million

Code: E02011001

01-28-2010

Cutting deeper at AstaZeneca

Code: E01281001

01-27-2010

Feds accuse J&J of kickback scheme with nursing home pharmacy company

Code: E01271002

01-25-2010

AIBioTech partners with AutoGenomics to expand molecular testing

Code: E01271003

01-07-2010

Abbott Labs settles state lawsuits for $22.5M

Code: E01011001

01-06-2010

Pfizer ends Phase III lung cancer drug study

Code: E01131001

January 2010

PREVIEW: ALA brings even more new offerings to LabAutomation2010

Code: E01131002

01-06-2010

Burrill & Co: Biotech recovers in second half of year and is poised to have a strong 2010

Code: E01131003

12-17-2009

Cubist acquires Calixa Therapeutics for $95 million

Code: E12210901

12-17-2009

PerkinElmer challenges MDS Analytical Technologies sale

Code: E12210902

12-14-2009

Caliper sells animal models subsidiary to Taconic Farms for $11 million

Code: E12140901

12-07-2009

Celgene, Gloucester Pharmaceuticals merge in $340 million cancer drug deal

Code: E12110901

12-07-2009

Pfizer, Lilly and Bayer fined for price-fixing in Switzerland

Code: E12110902

11-20-2009

BMS splits off Mead Johnson, signs potential $1 billion deal with Alder Biopharmaceuticals in quest to become biopharma

Code: E11230901

11-20-2009

Life Technologies eyes PCR market growth with BioTrove acquisition

Code: E11230902

11-16-2009

GSK inks potential half-billion-dollar deals with Nabi, Astex

Code: E11160901

11-16-2009

Duke University & Jubilant Organosys partner on global health disparities

Code: E11160902

11-16-2009

Pfizer cuts R&D sites, jobs following Wyeth acquisition

11-16-2009

Enzon sells specialty pharmaceutical business to Sigma-Tau in $327 million-plus deal

Code: E11160903

11-09-2009

FDA rejects Merck’s application for cholesterol combo drug

Code: E11110901

11-05-2009

IMS Health to be acquired by investment firms for $5.2 billion

11-03-2009

J&J may cut more than 8,000 jobs

Code: E11110902

11-03-2009

U.S. officials request more information on MDS-Danaher transaction

Code: E11030902

10-26-2009

Highlights from Neuroscience 2009

Code: E10280902

10-26-2009

Pfizer unit hit with record fine for misbranding

Code: E10280901

October 2009

Hydra Biosciences, Cubist form collaboration

10-12-2009

European regulators raid top pharmas for suspected antitrust activity

Code: E10140901

10-09-2009

MDS sells Central Labs business to Czura Thornton for $8 million

Code: E10140902

10-09-2009

IMS Health ups drug sales forecast

10-09-2009

NHLBI awards $170 million to fund stem cell research

10-07-2009

GenScript establishes biology research collaboration with Roche

09-28-2009

NIH funds four Centers of Excellence in Genomic Science

09-16-2009

PerkinElmer boosts reagents assets with purchase of GE Healthcare’s Catalog Radiochemical products

09-14-2009

Lilly slashes jobs, announces new operating model

Code: E09230901

09-08-2009

MDS sells mass spec business to Danaher, seeks buyer for pharma services business

09-08-2009

Warner Chilcott buys P&G’s pharma division for $3.1 billion

Code: E09090901

09-08-2009

Researchers use skin cells from type 1 diabetes patients to produce cells that make insulin

Code: E09090903

08-24-2009

Court decision prevents Teva from producing a generic version of Singulair, Merck’s best-selling drug

Code: E08280901

08-24-2009

Agilent, Varian mum on blockbuster deal

08-10-2009

BMS acquires Medarex for $2.1 billion

08-10-2009

Highlights from IBC Life Sciences’ DD&D Week

August 2009

House vote a victory for biotechs in biosimilars battle

07-20-2009

Cellular Dynamics International reprograms blood cells into stem cells using a small volume of human blood

07-13-2009

Sciele Pharma terminates agreement to acquire Victory Pharma

07-06-2009

J&J buys $1 billion stake in Elan to acquire Alzheimer’s program

07-06-2009

Biogen Idec and Acorda Therapeutics’ $500 million-plus deal produces mixed market reaction

06-23-2009

Lilly unveils new drug discovery initiative to foster open collaboration between company, global laboratory researchers

06-22-2009

Watson aims for global generic footprint with $1.75 billion Arrow Group acquisition

06-08-2009

GSK and Concert Pharmaceuticals to develop deuterium-modified drugs in deal worth up to $1 billion

06-08-2009

Report: 2008 was a near-record year for pharma mergers and acquisitions

05-22-2009

GSK, Oxford BioTherapeutics in $300 million oncology research deal

05-22-2009

Takeda to acquire IDM Pharma for $75 million

05-11-2009

Pharma, biotech industries rise to H1N1 challenge

05-11-2009

Sanofi pulls the plug on 13 clinical programs, ramps up M&A efforts

04-20-2009

J&J reports poor Q1 sales, announces job cuts

04-20-2009

Illumina, Agilent to co-market targeted resequencing solution

04-08-2009

Genentech pulls psoriasis drug from U.S. market

04-07-2009

Big Pharma firms deny ‘mega-merger’ rumors, announce plans to seek small- to mid-size acquisitions

04-07-2009

Analysts: Change in U.S. stem cell policy could create half-billion-dollar market

03-23-2009

Gilead’s $1.4 billion bid wins nod from CV Therapeutics’ board

03-23-2009

N.J. court denies class action in Merck Vioxx case

03-09-2009

Merck and Schering-Plough to merge in $41.1 billion deal

03-09-2009

U.S. Supreme Court rules against Wyeth in drug labeling case

02-23-2009

Galapagos targets high-stakes Alzheimer’s breakthrough

02-23-2009

Sanofi-aventis outlines R&D changes, eyes acquisitions

02-10-2009

Roche-Genentech deal goes hostile

02-10-2009

Astellas makes second unsolicited bid to acquire CV Therapeutics for $1 billion

01-26-2009

Pfizer to buy Wyeth for $68B, cut 800 R&D jobs

01-26-2009

Lilly pays $1.4 billion to end Zyprexa marketing probe

01-12-2009

Galapagos diabetes, obesity deal with Merck could top $233 million

01-12-2009

Alnylam and Cubist partner up in bringing RNAi therapy for RSV infection to market

12-19-2008

Abbott exercises option to buy Isis molecular Dx subsidiary Ibis Biosciences for $215 million

12-19-2008

Broad researchers develop more efficient method of pooled RNAi screening for cancer treatment

12-08-2008

Alpha-7 dog: Roche buys out Memory Pharmaceuticals for $50 million

12-08-2008

AstraZeneca and Teva settle generic Pulmicort squabble

11-21-2008

United Therapeutics gets rights for tadalafil PAH indication, Lilly gets equity stake

11-20-2008

Pfizer unveils new stem cell unit

11-11-2008

Osiris inks adult stem cell therapeutic deal with Genzyme potentially worth $1.3 billion

11-10-2008

Biogen Idec pays Genentech $31.5 million to join blood cancer drug development deal in United States

10-21-2008

Pfizer to settle Bextra and Celebrex lawsuits for $894 million

10-21-2008

International focus: GSK snags Egyptian mature products business of Bristol-Myers Squibb for $210 million

10-07-2008

Lilly emerges as ‘mystery’ ImClone bidder with $6.5 billion offer

10-07-2008

Pfizer to focus R&D programs on more ‘valuable’ diseases

09-22-2008

Bayer HealthCare nabs antibody and protease biotech Direvo for approximately $300 million

09-22-2008

BTG snatches up fellow UK biotech Protherics in £218 million, all-share deal

09-09-2008

Pfizer Inc., Medivation enter into Alzheimer’s drug development deal worth up to $725 million

09-09-2008

Japanese buying spree continues with $1.4B Shionogi-Sciele deal

08-25-2008

Back in the game: PDL BioPharma inks development deal with Bristol-Myers Squibb for multiple myeloma candidate elotuzuma

08-25-2008

Alpharma spurns $1.4 billion unsolicited acquisition offer from King Pharmaceuticals

08-11-2008

Lilly sells Greenfield labs, signs 10-year, $1.6 billion development deal with Covance

08-11-2008

Valeant sells Western, Eastern Europe operations to Meda for $392 million, companies sign joint marketing ventures

07-21-2008

Roche offers $43.7 billion for remainder of Genetech shares

07-21-2008

Generics are hot: Teva snaps up Barr for $7.4 billion

07-09-2008

Shire to acquire German pharma Jerini AG

07-09-2008

Fresenius AG to buy APP Pharmaceuticals for $3.7 billion

06-25-2008

Sanofi-aventis to make $2.6 billion competing bid for generic drug maker Zentiva

06-25-2008

Genzyme, Isis ink mipomersen licensing deal

06-25-2008

Flow cytometry for all

06-12-2008

Astex inks oncology deal with J&J’s Janssen Pharmaceutica that could yield $500 million

06-12-2008

BREAKING NEWS: Invitrogen to acquire Applied Bio for $6.7 billion

06-12-2008

Daiichi Sankyo to take control of Ranbaxy in $4.6B deal

05-28-2008

Alnylam strikes deal with Takeda that could top $1 billion

05-28-2008

Sonus Pharmaceuticals, OncoGenex Technologies announce merger

05-14-2008

Osiris sells Osteocel to NuVasive, in deal that could total $85 million

05-14-2008

Intercell expands late-stage pipeline with $189 million Iomai acquisition

04-23-2008

GSK to acquire Sirtris for $720 million

04-23-2008

Roche snaps up PIramed for $175 million

04-23-2008

AstraZeneca and Ranbaxy reach Nexium settlement

04-09-2008

Pfizer scraps Phase III melanoma drug trial

04-09-2008

Schering-Plough slashes costs in wake of Vytorin criticism

04-09-2008

Neurogen moves to advance clinical development programs

03-26-2008

Takeda will dole out $1.5 billion to Abbott to end TAP joint venture

03-26-2008

Rosetta Genomics test use miRNAs for cancer of unknown primary diagnostic

03-26-2008

Cenix BioScience signs research agreement with AstraZeneca, CellCentric

03-11-2008

Pfizer to acquire Serenex to extend oncology pipeline and access novel technology platform

03-11-2008

Marcadia Biotech and Merck enter diabetes, obesity collaboration

03-11-2008

Genome-wide association study on Parkinson’s publicly available through NHGRI, NCBI

February 2008

Acceleron, Celgene work together on ACE-011

02-27-2008

Sirtris Pharma, NCI team up for SIRT1 cancer study

02-27-2008

Abbott, Genentech, and WEHI in cancer research collaboration

02-13-2008

EKR Therapeutics, PDL BioPharma sign asset purchase deal

02-12-2008

GE Healthcare to acquire Whatman

02-12-2008

Royalty Pharma, InNexus Biotechnology expand royalty rights agreement

02-12-2008

New deal

02-12-2008

NextGen forges commercial alliance with Paragon

January 2008

Helicos arranges $20 million loan with GE

01-23-2008

Roche sweetens pot to nab Ventana

01-23-2008

Consortium to tackle genome research project

01-23-2008

Knome commences whole-genome sequencing process for first clients

01-09-2008

Elan, Wyeth kick off North American leg of Phase 3 Program for bapineuzumab in Alzheimer’s Disease

01-09-2008

NextGen Sciences announces alliance with Paragon Bioservices Inc.

01-09-2008

Cubist Pharmaceuticals acquires Illumigen Biosciences

12-17-2007

GSK orders Chinese

12-17-2007

RXi licenses RNAi

12-17-2007

Never a bride

12-11-2007

North meets South naturally

12-11-2007

Cardinal losing control(led)?

12-11-2007

Anti-infective alliance

11-27-2007

Be vaccine prepared

11-27-2007

More vaccine news

11-27-2007

GSK, OncoMethylome collaborate

11-14-2007

Affymetrix and Empire Genomics sign licensing agreement

11-13-2007

Agilent gains Velocity

11-12-2007

Chemoinformatics program launched Upstream

11-12-2007

NIAID expands vaccine efforts

10-22-2007

Flu vaccine firmly planted?

September 2007

Layoffs and retrenchment

10-22-2007

Merck, Protiva make nice

10-09-2007

Cyclacel aligns its business

10-09-2007

McKesson expands specialty pharma ops

10-09-2007

Aberdeen there, buying that

09-24-2007

A SMaRT buy?

September 2007

Nanogen changing gears

09-24-2007

Allergan overactive acquisition

09-10-2007

Nanobody knows…

09-10-2007

Animal testing alternative?

09-10-2007

Ventana acquires Spring BioScience

08-21-2007

CLX snags Dx property

08-20-2007

Radio(pharm) ga-ga

August 2007

Amgen to stop the bleeding

08-06-2007

Moving expenses

08-06-2007

More than the therapeutic sum

08-06-2007

Drug delivery acquisition

July 2007

Meda buys MedPointe for $0.8B

07-23-2007

Wound care technology agreement

07-23-2007

Expanding enzyme business

07-09-2007

Roche establishes RNAi center

07-09-2007

Another RNAi collaboration

07-09-2007

Novavax licenses virus-like particles

06-26-2007

Roche, Toyama collaborate on RA

06-26-2007

Modeling Huntington’s

06-26-2007

Roche to acquire NimbleGen

06-08-2007

Amgen goes shopping

06-08-2007

IBM opens infectious disease software

06-08-2007

Cambria, Pfizer collaborate on vet meds

June 2007

Major HPV Dx move

May 2007

Bausch & Lomb eyes $4.5B

05-21-2007

Inverness wins Biosite battle

05-21-2007

Tripos finds new suitor

05-07-2007

Brazil breaks Merck patent

05-07-2007

GPC Biotech consolidates discovery

05-07-2007

Firmly planted in glyco-engineering

04-23-2007

Novartis bets a billion

04-23-2007

Wyeth disputes cancer-HRT link

04-23-2007

AZ bids for MedImmune

04-09-2007

Roche to acquire BioVeris

April 2007

Agilent adds kits and consumables

04-09-2007

Discovery collaboration

March 2007

mAb quest

03-23-2007

Sugar-coated zebrafish

03-23-2007

Merck signs natural product agreement

03-13-2007

Avalon, Merck tackle cancer

03-13-2007

Protein therapeutic license

03-13-2007

Takeda acquires Paradigm

02-23-2007

Sartorius combines with Stedim

February 2007

Shire buys New River

02-23-2007

Learning about liver toxicity

02-09-2007

GE grants biomagnetic license to ABI

February 2007

Inflazyme to cut jobs

02-09-2007

Corautus-VIA to merge

01-22-2007

Novo Nordisk drops small molecules

01-22-2007

Caliper launches service arm

01-22-2007

Wako to market biopathway system

01-09-2007

LabAutomation 2007

01-08-2007

Ecopia, Caprion combine; divest proteomics

01-08-2007

Companies to integrate protein platforms

01-08-2007

Looking to LabAutomation

December 2006

Exelixis, BMS collaborate on cancer

12-21-2006

Chew bet you

12-21-2006

PE to buy Euroscreen Products

November 2006

Galapagos acquires Inpharmatica

12-11-2006

Tackling Alzheimer’s

12-11-2006

Halozyme, Roche collaborate

11-17-2006

Pretty proteomic pictures

11-17-2006

Playing chicken

11-17-2006

Dynamic diabetes duo

11-06-2006

Merck to acquire Sirna

11-06-2006

CEM opens Indian operations

11-06-2006

LEO Pharma, BioFocus DPI screen natural products

October 2006

GE, BAC collaborate on media

10-23-2006

Non-viral gene delivery

10-23-2006

Covance licenses PK product

10-09-2006

Acambis offloads vaccine assets

10-09-2006

Expanding protein purification capacity

10-09-2006

Animal vaccine agreement

09-25-2006

Biogen, Alnylam target CNS disease

09-25-2006

Luminex, Exiqon push microRNAs

September 2006

Pfizer, Odyssey Thera collaborate

09-08-2006

GBI goes to Hollywood

09-08-2006

Fragment-based drug discovery

08-22-2006

Leahy pushes for low-cost drugs

08-22-2006

Developing a microbicide strategy

08-07-2006

Gene Logic to lay off staff

08-07-2006

Amgen, Predix to collaborate

08-07-2006

Enzyme supply agreement

07-21-2006

Chemical synthesis patent

07-21-2006

Metabolic disorder initiative launched

07-21-2006

GeneGo, Elsevier MDL to collaborate

07-07-2006

Predicant Biosciences founds Pathwork Diagnostics

07-07-2006

Novozymes buys Delta Biotech

06-23-2006

Evotec, Roche target CNS

06-23-2006

Peakdale pushes capacity…

06-23-2006

…and Galapagos keeps pace

May 2006

Gilead buys API capabilities

06-12-2006

May 2006

05-22-2006

05-22-2006

May 2006

05-08-2006

APP NOTE: Transforming cells

05-08-2006

Sigma-Aldrich expands cGMP capacity

05-08-2006

DNASTAR lends a hand

04-21-2006

Agilent expands RNA portfolio

04-21-2006

Benitec reduces costs, cuts workforce

April 2006

Bruker family reunion

04-19-2006

Peptide chip shots

04-19-2006

Monitoring metabolites

04-16-2006

Pushing biomarker limits

04-16-2006

Classifying drugs

April 2006

APP NOTE: Identifying PTMs

Back

PAGE UTILITIES

	PRINT CURRENT PAGE
	SEND THIS PAGE TO A COLLEAGUE

Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600 | Fax: 440-331-7563